FIELD: chemical-and pharmaceutical industry.
SUBSTANCE: claimed agent contains DNA sodium salt isolated from bovine testis and is useful in peroral application in form of powder, tablets, pellets, and capsules for treatment and prophylaxis of anemia, secondary immunodeficit conditions and as bracing agent. Agent may additionally contains biologically active components and filler.
EFFECT: effective and convenient agent having antianemic, immunomodulating and adaptogenic actions.
3 cl, 3 ex, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING ANTIOXIDANT, ANTITUMOR, ANTI-INFLAMMATORY, ANTIBACTERIAL, HYPOTENSIVE, IMMUNOMODULATING AND ADAPTOGENIC EFFECT | 2005 |
|
RU2308961C2 |
| AGENT ELICITING ANTIOXIDANT, ANTITUMOR, ADAPTOGENIC AND IMMUNOMODULATING EFFECTS | 2003 |
|
RU2224535C1 |
| AGENT HAVING ANTIOXIDANT, ANTI-TUMOR, IMMUNOMODULATORY, ANTI-DIABETIC AND ANTI-BACTERIAL ACTION | 2015 |
|
RU2598349C1 |
| COMPOSITION FOR PREVENTION OF IRON DEFICIENCY ANEMIA | 2012 |
|
RU2491948C1 |
| PHARMACEUTICAL COMPOSITION WITH ADAPTOGENIC ACTIVITY | 2021 |
|
RU2781828C1 |
| METHOD OF ISOLATION OF DNA SODIUM SALT FROM ANIMAL TISSUES | 1997 |
|
RU2139068C1 |
| METHOD FOR ISOLATING DNA SODIUM SALT FROM ANIMAL TISSUE | 2005 |
|
RU2302876C1 |
| METHOD OF DNA TABLET MAKING | 2000 |
|
RU2170084C1 |
| SYGETIN BASED PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2346684C2 |
| METHOD FOR ACCOMPANYING TREATMENT OF LYMPHOBLAST LEUCOSIS | 2006 |
|
RU2320367C1 |
